COMMUNIQUÉS West-GlobeNewswire

Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024

30/08/2024 - 13:00

PRINCETON, N.J., Aug. 30, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor conferences in September. Morgan [...]

Passage Bio to Present at H.C. Wainwright 26th Annual Global Investment Conference

30/08/2024 - 13:00

PHILADELPHIA, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced [...]

Psyence Biomed Announces Registration Statement on Form F-1 for Up to $25 Million Equity Line of Credit with White Lion Capital, LLC, Declared Effective by SEC

30/08/2024 - 13:00

NEW YORK, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”) today announced that the registration statement pertaining to its previously announced $25 million [...]

Trading by management and close relations of management

30/08/2024 - 12:17

Please read the full announcement in PDF Attachment 2024_29_Trading_By_Management

BioConnection appoints Dr. Gary M. Phillips as new Chairman of its Supervisory Board

30/08/2024 - 10:43

OSS, The Netherlands – 30 August 2024, BioConnection , a leading Dutch contract development and manufacturing organization (CDMO) in the pharmaceutical industry, today announced the appointment of Dr. Gary M. Phillips [...]

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

30/08/2024 - 10:39

Bagsværd, Denmark, 30 August 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance [...]

HUTCHMED Provides Update on Fruquintinib for Second-Line Gastric Cancer in China

30/08/2024 - 06:30

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Aug. 30, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has voluntarily withdrawn its supplemental New [...]

Raw Garden Announces End of Summer and Labor Day Deals

30/08/2024 - 02:50

Premier cannabis cultivator offers up to 40% off at participating retailers across California SANTA BARBARA, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Raw Garden , California's premier cannabis cultivator, manufacturer [...]

Metagenomi Presents AI-Enabled Advancements of SMART Editing Platform at the Cold Spring Harbor Laboratory CRISPR Frontiers Conference

30/08/2024 - 01:32

AI-generated, compact SMART nucleases demonstrated robust genome editing activity in vitro in mammalian cells at multiple therapeutically relevant loci Compact SMART genome editing tools that fit within delivery [...]

ARCA biopharma Announces Completion of Merger with Oruka Therapeutics and Implementation of Reverse Stock Split

29/08/2024 - 22:50

The combined company will operate as “Oruka Therapeutics, Inc.” with its common stock traded on Nasdaq under trading symbol “ORKA” effective Tuesday, September 3, 2024 WESTMINSTER, Colo., Aug. 29, 2024 (GLOBE NEWSWIRE [...]

Ultragenyx to Participate in Investor Conferences in September

29/08/2024 - 22:30

Morgan Stanley 22 nd Annual Global Healthcare Conference on September 4 Cantor Global Healthcare Conference on September 17 Bank of America Global Healthcare Conference on September 18 NOVATO, Calif., Aug. 29, 2024 ( [...]

Umoja Biopharma to Participate in Upcoming Investor Conferences in September

29/08/2024 - 22:30

SEATTLE, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc. (Umoja), a transformative immunotherapy company creating off-the-shelf treatments that aim to extend the reach and effectiveness of CAR-T cell therapies [...]

StateHouse Reports Second Quarter 2024 Financial Results

29/08/2024 - 22:30

Q2 2024 Net Revenue Increase d 10% to $27.8 Million and Gross Margin Remains Strong at 50.8 % Achieved Positive Net Income of $0.2 Million and Adjusted EBITDA of $4.9 Million in Q2 2024 SAN DIEGO and TORONTO, Aug. 29, [...]

WORK Medical Technology Group LTD Announces Partial Exercise of Underwriters’ Over-Allotment Option

29/08/2024 - 22:30

Hangzhou, China, Aug. 29, 2024 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (the “Company”), a supplier of medical devices in China, today announced the underwriter of its initial public offering [...]

Clearmind Medicine Announces Publication of its Patent Application for Innovative Ketamine-Based Combination Treatment

29/08/2024 - 22:25

Vancouver, Canada, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel [...]

SciSparc-Clearmind Medicine Collaboration Leads to Publication of Application for Innovative Ketamine-Based Combination

29/08/2024 - 22:25

TEL AVIV, Israel, Aug. 29, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders [...]

Kane Biotech Announces Second Quarter 2024 Financial Results

29/08/2024 - 22:15

Company Realizes $10.4M Gain on the Sale of STEM WINNIPEG, Manitoba, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) today announces its second [...]

Sana Biotechnology to Present at September 2024 Investor Conferences

29/08/2024 - 22:05

SEATTLE, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its [...]

Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

29/08/2024 - 22:05

Strong balance sheet with successful completion of upsized $179.0 million initial public offering Treatment initiated in the first patient in an investigator-initiated basket trial of AlloNK® exploring multiple [...]